The Roswell Park Cancer Institute Faculty Forum is a seminar program, which invites prominent researchers to present a lecture in their area of expertise. The Institute has organized a committee of the Institute’s senior scientists and clinicians to select speakers who are recognized for their achievements and stature in basic and clinical cancer research.

In contrast to a departmental seminar, this is an Institute-wide presentation. Senior faculty, postdoctorals, residents, and graduate students with a wide range of scientific/clinical interest and expertise are encouraged to attend. Each presentation will consist of a 50 to 55 minute presentation, followed by 5 or 10 minutes of questions and answers.

Physician participants in this program will be awarded AMA Category 1 credit.  Time: 8:00-9:00 AM Location: Zebro Family Conference Room, Center for Genetics & Pharmacology, BLSC 

2009
Jan. 7	David L.Dunn, MD, PhD Vice President for Health Sciences at the University at Buffalo/State University of New York	Reconfiguring Health Care and Health Science Education in Western New York	Donald Trump, MD
Feb. 4	Stanton Gerson, MD Director, Case Comprehensive Cancer Center	Director's Conference Base Excision Repair: A Target for Cancer Therapeutic Combinations	Donald Trump, MD
Feb. 11	John Bell, PhD Ottawa Health Research Institute	Oncolytic Viruses as  Cancer Therapeutics	Donald Trump, MD
Feb. 25	Robert Croyle, PhD Director, Division of Cancer Control & Population Sciences, National Cancer Institute	Current Challenges in Cancer Control and Population Sciences	Christine Ambrosone, PhD
March 4	William Nelson, MD, PhD Director, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Director's Conference New Insights into the Molecular Pathogenesis of Human Prostate Cancer	Donald Trump, MD
Mar.11	Francis Ouellette, MS Associate Director, Informatics and Bio-computing, Principal Investigator, Ontario Institute for Cancer Research	Bioinformatics Challenges at a Cancer Institute	Alan Hutson, PhD
April 1	Cancelled
April 8	Wafik El-Deiry, MD, PhD Professor of Medicine, Genetics and Pharmacology and Co-Program Leader, Radiation Biology & Imaging Program Abramson Comprehensive Cancer Center	Modulation of Death Receptor Signaling for Therapeutic Gain	Andrei Gudkov, PhD
May 6	Carol Taylor, RN, MSN, PhD  Director, Center for Clinical Bioethics Georgetwon University	Institutional Integrity and Organizational Ethics	Camille Wicher, Esq., RN, MSN
May 13	Aaron Fenster, PhD Platform Leader, Imaging Pipeline, Imaging Research Laboratories, Robarts Research Institute	3-D Ultrasound-Guided Prostate Biopsy	Donald Trump, MD
May 20	TBA
May 27	Gennadi V. Glinsky, MD, PhD Head, Translational & Functional Genomics Laboratory, Ordway Cancer Center	Dissecting Human Genomes to Understand 'Stemness' and Cancer	David Gold, PhD
June 3	George Weiner, MD Director, Holden Comprehensive Cancer Center at The University of Iowa	Director's Conference Monoclonal Antibody Therapy of Cancer: Making Better Antibodies, and Making Antibodies Better	Donald Trump, MD
June 10	Jeffrey Rosen, PhD C.C. Bell Professor, Dept. of Molecular & Cellular Biology, Baylor College of Medicine	Weiss Memorial Lecture  Intrinsic Therapeutic Resistance of Breast Cancer Stem Cells	Kenneth Gross, PhD
July 1	TBA
July 8	TBA
July 22	Nahum Sonenberg, PhD James McGill Professor, Rosalind and Morris Goodwin Cancer Centre	Cori Lecture Translational Control of Cancer	Charles Wenner, PhD
Aug. 5	TBA
Aug. 12	Michelle LeBeau, PhD Director, University of Chicago Cancer Research Center	Director's Conference	Donald Trump, MD
Aug. 26	TBA
Sept. 2	TBA
Sept. 9	TBA
Sept. 30	Edward Benz, Jr., MD Director, Dana-Farber Cancer Institute	Director's Conference Regulated Pre-mRNA Splicing and Multiple Functions of the Gene Products of the Cytoskeletal Protein 4.1R	Donald Trump, MD
Oct. 7	TBA
Oct. 14	Douglas Hanahan, PhD Professor, Biochemistry, UCSF	Mihich Lecture Mechanisms and Therapeutic Targeting of the Tumor Microenvironment	David Goodwin, PhD
Nov. 4	TBA
Dec. 2	TBA
Dec. 9	TBA